Simulations Plus, Inc.

greetings and welcome to the simulations plus fourth quarter fiscal 2022 financial results conference call at this time all participants are in a listen only mode a brief question and answer session will follow the formal presentation if anyone should require operator assistance during the conference please press star then zero on your telephone keypad as a reminder this conference is being recorded It is now my pleasure to introduce Brian Siegel from Hayden IR. Thank you, Mr. Siegel. You may now begin.

Good afternoon, everyone.

Welcome to our fourth fiscal 2022 financial results conference call. With me today is our CEO, Sean O'Connor, and CFO, Will Frederick. After their portion of the call, we'll open the floor to questions. Before we begin, I want to remind everyone that the matters discussed in this presentation are forward-looking statements that involve risks and uncertainties, except for historical information. Words like believe, expect, and anticipate mean that these are our best estimates as of this call. Still, there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from these statements. Factors that could cause or contribute to such differences include, but are not limited to, our ability to maintain our competitive advantages, acceptance of new software, and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, our ability to identify and close acquisitions on terms favorable to the company, and a sustainable market. Further information on the company's risk factors is contained in the company's quarterly and annual reports and filed with the United States Securities and Exchange Commission. With that said, I'd like to turn the call over to Sean O'Connor. Sean?